Ignite Creation Date:
2025-12-24 @ 11:48 PM
Ignite Modification Date:
2026-01-18 @ 11:24 AM
Study NCT ID:
NCT06518551
Status:
RECRUITING
Last Update Posted:
2025-12-11
First Post:
2024-07-18
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Elotuzumab + Iberdomide + Dexamethasone Post Ide-Cel in RRMM
Sponsor:
Omar Nadeem, MD
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
24-189
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None